| Cancer in sub-Saharan Africa: a lancet oncology commission W Ngwa, BW Addai, I Adewole, V Ainsworth, J Alaro, OI Alatise, Z Ali, ... The Lancet Oncology 23 (6), e251-e312, 2022 | 134 | 2022 |
| Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants S Gantt, J Orem, EM Krantz, RA Morrow, S Selke, ML Huang, JT Schiffer, ... The Journal of infectious diseases 214 (1), 36-44, 2016 | 77 | 2016 |
| Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial SE Krown, CB Moser, P MacPhail, RM Matining, C Godfrey, SR Caruso, ... The Lancet 395 (10231), 1195-1207, 2020 | 69 | 2020 |
| Challenges faced by cancer patients in Uganda: implications for health systems strengthening in resource limited settings A Nakaganda, K Solt, L Kwagonza, D Driscoll, R Kampi, J Orem Journal of Cancer Policy 27, 100263, 2021 | 30 | 2021 |
| Turnaround time and barriers to treatment of newly diagnosed cancer in Uganda: a mixed-methods longitudinal study S Kibudde, E Namisango, A Nakaganda, M Atieno, J Bbaale, M Nabwana, ... African Health Sciences 22 (1), 327-37, 2022 | 6 | 2022 |
| Expanding best practices for implementing evidence-based cancer control strategies in Africa: the 2019–2020 Africa cancer research and control ECHO program A Nakaganda, MK Cira, K Abdella, F Uwinkindi, C Mugo-Sitati, K Duncan Journal of Cancer Policy 28, 100286, 2021 | 5 | 2021 |
| Estimating cancer incidence in Uganda: a feasibility study for periodic cancer surveillance research in resource limited settings A Nakaganda, A Spencer, J Orem, C Mpamani, H Wabinga, S Nambooze, ... BMC cancer 23 (1), 772, 2023 | 2 | 2023 |
| Prevalence, trends and distribution of lifestyle cancer risk factors in Uganda: a 20-year systematic review A Nakaganda, I Mbarusha, A Spencer, L Patterson, I Gemmell, A Jones, ... BMC cancer 23 (1), 311, 2023 | 1 | 2023 |
| Neglected Elements of Cancer Control During the COVID-19 Pandemic in Africa: Call for Action from 2019-2020 African Cancer Research and Control ECHO Programme A Nakaganda, N Lasebikan, EM Garton, B Kithaka, MK Cira Cancer Epidemiology, Biomarkers & Prevention 30 (7_Supplement), 11-11, 2021 | 1 | 2021 |
| Risk of COVID‐19 death for people with a pre‐existing cancer diagnosis prior to COVID‐19‐vaccination: A systematic review and meta‐analysis J Steinberg, S Hughes, H Hui, MJ Allsop, S Egger, M David, M Caruana, ... International Journal of Cancer 154 (8), 1394-1412, 2024 | | 2024 |
| Cancer patterns in Arua district, Uganda: a hospital-based retrospective study BA Sharon, A Nakaganda, G Fadhil, M June, E Anecho, G Aniku, ... ecancermedicalscience 18, 2024 | | 2024 |
| Cancer Control Through Surveillance: Harmonised Cancer Registration Guidelines for East Africa A Nakaganda, H Wabinga, C Kahesa, F Uwinkindi, J Nsengiyumva, ... Cancer Epidemiology, Biomarkers & Prevention 32 (6_Supplement), 17-17, 2023 | | 2023 |
| How COVID-19 exposed pre-existing roadblocks for cancer control in Africa: strategies, lessons and recommendations from the 2019–2020 Africa Cancer Research and Control ECHO A Nakaganda, N Lasebikan, EM Garton, B Kithaka, E Garanganga, ... ecancermedicalscience 17, 2023 | | 2023 |
| CANCER INCIDENCE AMONG CHILDREN IN UGANDA: A RETROSPECTIVE POPULATION-BASED STUDY, 2013-2017 A Nakaganda, R Angom, J Orem, J Kambugu PEDIATRIC BLOOD & CANCER 69, 2022 | | 2022 |
| HEALTH WORKFORCE NEEDS FOR OPTIMAL CANCER CARE IN RESOURCE-LIMITED SETTINGS: FACTORS AFFECTING EMPLOYEE PRODUCTIVITY IN UGANDA S Kwagala, A Obote, A Jatho, E Anecho, A Nakaganda, J Orem PEDIATRIC BLOOD & CANCER 69, S449-S450, 2022 | | 2022 |
| Demonstration of Impact Through the Evaluation of the 2020-2021 Africa Cancer Research and Control ECHO N Lasebikan, A Nakaganda, T Fadelu, P Ibeka, L Haskins, M Cira JCO Global Oncology 8 (Supplement_1), 37-37, 2022 | | 2022 |
